Sachs Asset Management, L.p. Goldman
Former 10% Owner at Attovia Therapeutics, Inc. (ATTO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$802K
Total bought / sold$10.3M / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Buy | 85,000new position | $21.00 | $1.8M | -22.8% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 98884,012 held (−1%) | $22.03 | $22K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 44783,565 held (−1%) | $21.87 | $10K | -25.9% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 1,33282,233 held (−2%) | $22.03 | $29K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 20082,033 held (−0%) | $22.05 | $4K | -26.5% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 1,55680,477 held (−2%) | $22.06 | $34K | -26.5% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 3,40277,075 held (−4%) | $22.02 | $75K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 20076,875 held (−0%) | $22.10 | $4K | -26.7% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 48076,395 held (−1%) | $21.55 | $10K | -24.8% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 10076,295 held (−0%) | $22.11 | $2K | -26.7% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 75375,542 held (−1%) | $21.97 | $17K | -26.2% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 67274,870 held (−1%) | $22.02 | $15K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 6,97067,900 held (−9%) | $22.03 | $154K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 40067,500 held (−1%) | $22.02 | $9K | -26.4% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 1,18066,320 held (−2%) | $21.84 | $26K | -25.8% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 1,04065,280 held (−2%) | $22.05 | $23K | -26.5% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 30064,980 held (−0%) | $20.84 | $6K | -22.2% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 44364,537 held (−1%) | $21.78 | $10K | -25.6% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 20064,337 held (−0%) | $22.05 | $4K | -26.5% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 70063,637 held (−1%) | $22.07 | $15K | -26.6% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 1,16362,474 held (−2%) | $22.19 | $26K | -26.9% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 10062,374 held (−0%) | $21.99 | $2K | -26.3% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 6,76355,611 held (−11%) | $21.61 | $146K | -25.0% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Sell | 76,418 | $21.04 | $1.6M | -23.0% |
| Aug 28SEC | ATTOAttovia Therapeutics, Inc. | Buy | 500,0003,020,632 held (+20%) | $17.00 | $8.5M | -4.6% |
- Buy
Former 10% Owner Sachs Asset Management, L.p. Goldman bought $1.8M of ATTO at $21.00 — first open-market purchase in our records; opens a new position.
- Buy
Former 10% Owner Sachs Asset Management, L.p. Goldman bought $8.5M of ATTO at $17.00 — largest purchase by this insider in our records.